SCHEMBL6991028

SCHEMBL6991028

Nc1ccc(Nc2ncnc3cnc(N[C@H]4CC[C@H](O)CC4)nc23)cc1[N+](=O)[O-]

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 2/20 0.55
GSK3B P49841 2/20 0.55
BRAF P15056 5/20 0.51
EGFR P00533 5/20 0.48
ERBB2 P04626 1/20 0.48
HPGD P15428 1/20 0.48
HTT P42858 1/20 0.48
MAPK8 P45983 1/20 0.42
MAPK9 P45984 1/20 0.42
TYRO3 Q06418 2/20 0.42
MERTK Q12866 2/20 0.42
FLT3 P36888 2/20 0.42
GAS6 Q14393 1/20 0.42
ABCG2 Q9UNQ0 1/20 0.40
SYK P43405 2/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
AXL P30530 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6991037 1.00 GSK3A (0.55) GSK3AGSK3BBRAFEGFRERBB2
SCHEMBL6992432 0.90 GSK3A (0.55) GSK3AGSK3BBRAFEGFRERBB2
SCHEMBL6992428 0.90 GSK3A (0.55) GSK3AGSK3BBRAFEGFRERBB2
SCHEMBL8313619 0.86 GSK3A (0.56) GSK3AGSK3BBRAFEGFRERBB2
SCHEMBL8313626 0.86 GSK3A (0.56) GSK3AGSK3BBRAFEGFRERBB2
SCHEMBL8313945 0.86 GSK3A (0.56) GSK3AGSK3BBRAFEGFRERBB2
SCHEMBL8313754 0.82 BRAF (0.51) GSK3AGSK3BBRAFEGFRERBB2
SCHEMBL8313760 0.82 BRAF (0.51) GSK3AGSK3BBRAFEGFRERBB2
SCHEMBL8315091 0.81 ABCG2 (0.54) GSK3AGSK3BBRAFEGFRERBB2
SCHEMBL8315344 0.80 EGFR (0.64) GSK3AGSK3BBRAFEGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888351-B1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION THOMAE GMBH DR K (DE) 2003-10-15 EP claimed
EP-0888351-A1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION Dr. Karl Thomae GmbH (DE) 1999-01-07 EP claimed
WO-1997032880-A1 PYRIMIDO[5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION DR. KARL THOMAE GMBH (DE) 1997-09-12 WO claimed
EP-0888351-B1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION THOMAE GMBH DR K (DE) 2003-10-15 EP disclosed
EP-0888351-A1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION Dr. Karl Thomae GmbH (DE) 1999-01-07 EP disclosed
WO-1997032880-A1 PYRIMIDO[5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION DR. KARL THOMAE GMBH (DE) 1997-09-12 WO disclosed